Financials Vaso Corporation

Equities

VASO

US92233F1021

Advanced Medical Equipment & Technology

Delayed OTC Markets 12:51:49 2024-05-14 pm EDT 5-day change 1st Jan Change
0.2598 USD -3.78% Intraday chart for Vaso Corporation -0.08% -14.82%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4.235 5.147 15.55 9.553 28.9 53.47
Enterprise Value (EV) 1 12.1 16.57 21.16 4.284 10.38 30.21
P/E ratio -1.13 x 128 x 42.5 x 1.54 x 2.41 x 11.1 x
Yield - - - - - -
Capitalization / Revenue 0.06 x 0.07 x 0.22 x 0.13 x 0.36 x 0.66 x
EV / Revenue 0.16 x 0.22 x 0.3 x 0.06 x 0.13 x 0.37 x
EV / EBITDA -10.1 x 4.49 x 6.54 x 0.64 x 1.16 x 5.82 x
EV / FCF -3.83 x -6.97 x 3.85 x 1.14 x 1.77 x 13.8 x
FCF Yield -26.1% -14.3% 26% 87.9% 56.4% 7.26%
Price to Book 0.76 x 0.89 x 3.06 x 0.84 x 1.26 x 1.99 x
Nbr of stocks (in thousands) 166,720 172,702 174,715 175,128 175,128 175,319
Reference price 2 0.0254 0.0298 0.0890 0.0546 0.1650 0.3050
Announcement Date 4/15/19 4/14/20 5/5/21 3/31/22 3/31/23 4/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 73.98 75.75 69.85 75.58 80.02 81.02
EBITDA 1 -1.202 3.693 3.234 6.659 8.956 5.194
EBIT 1 -3.724 1.012 0.772 2.819 7.033 4.195
Operating Margin -5.03% 1.34% 1.11% 3.73% 8.79% 5.18%
Earnings before Tax (EBT) 1 -4.119 0.15 0.357 6.251 7.13 4.905
Net income 1 -3.734 0.039 0.358 6.1 11.87 4.805
Net margin -5.05% 0.05% 0.51% 8.07% 14.84% 5.93%
EPS 2 -0.0226 0.000232 0.002095 0.0355 0.0686 0.0275
Free Cash Flow 1 -3.161 -2.377 5.494 3.766 5.858 2.195
FCF margin -4.27% -3.14% 7.87% 4.98% 7.32% 2.71%
FCF Conversion (EBITDA) - - 169.89% 56.55% 65.41% 42.25%
FCF Conversion (Net income) - - 1,534.74% 61.74% 49.34% 45.67%
Dividend per Share - - - - - -
Announcement Date 4/15/19 4/14/20 5/5/21 3/31/22 3/31/23 4/1/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 7.86 11.4 5.61 - - -
Net Cash position 1 - - - 5.27 18.5 23.3
Leverage (Debt/EBITDA) -6.542 x 3.094 x 1.734 x - - -
Free Cash Flow 1 -3.16 -2.38 5.49 3.77 5.86 2.19
ROE (net income / shareholders' equity) -50.6% 0.68% 7.62% 74.4% 69.5% 19.6%
ROA (Net income/ Total Assets) -4.34% 1.21% 0.92% 3.43% 7.03% 3.56%
Assets 1 86.03 3.232 38.86 177.9 168.8 135.1
Book Value Per Share 2 0.0300 0.0300 0.0300 0.0600 0.1300 0.1500
Cash Flow per Share 2 0.0200 0.0100 0.0400 0.0300 0.0700 0.0600
Capex 1 2.59 1.21 1 0.42 0.57 0.73
Capex / Sales 3.5% 1.59% 1.43% 0.55% 0.71% 0.9%
Announcement Date 4/15/19 4/14/20 5/5/21 3/31/22 3/31/23 4/1/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. VASO Stock
  4. Financials Vaso Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW